Comparison
BPC-157 vs TB-500
The two healing peptides people most often stack — different mechanisms, different cadences, often logged together in soft-tissue protocols.
BPC-157 and TB-500 both show up in the same conversations, but they aren't interchangeable. The table above lays the vial math side by side so you can see how concentration, doses-per-vial, and weekly cadence actually compare. The sections below walk through what each one is, how each is studied, and how each shows up in a tracked log — in plain English, no recommendations.
BPC-157 vs TB-500: the actual decision
These two molecules are stacked together more often than they are compared, but the comparison is worth making because the mechanisms are genuinely different. BPC-157 is a fragment of a gastric protective peptide; the published animal work centers on tendon and ligament healing, gut barrier integrity, and angiogenesis. TB-500 is a synthetic version of the active region of thymosin beta-4; the animal work centers on actin sequestration, cell migration, and broad systemic recovery. Both are research peptides — there is no human approval for either, and the body of human data is much thinner than the headline animal numbers.
Cadence is the most-tracked difference. BPC-157 is typically logged at daily or twice-daily small doses (commonly 200–500 mcg per administration); TB-500 is typically logged at larger doses two or three times per week (commonly 2–5 mg per administration). The protocols are not interchangeable, and the unit math on a 100-unit syringe lands in completely different ranges. The calculator pages linked below handle either molecule once vial concentration is set.
Mechanism, cadence, and what shows up in a log
Stack logging is where most readers actually arrive at this comparison. The standard workflow is one log entry per molecule per administration, with the two timelines tracked in parallel rather than merged into a single field. That separation matters because the two cadences are different — a merged log makes it impossible to attribute a recovery signal to either peptide individually, while parallel logs let you see whether the BPC-157 daily rhythm or the TB-500 thrice-weekly cadence is doing the work.
Reconstitution is identical in mechanics — lyophilized powder, bacteriostatic water, U-100 syringe — but vial sizes and typical reconstitution volumes differ. A 5 mg BPC-157 vial reconstituted with 2 mL hits 2.5 mg/mL; a 5 mg TB-500 vial reconstituted with 2 mL hits the same concentration but is dosed at 2 mg per administration instead of 0.25 mg, which is the entire reason TB-500 vials empty faster. The vial-duration calculator linked below shows the difference at your own vial sizes.
Logging BPC-157 alongside TB-500
For the BPC-157 vs TB-500 decision specifically, the calendar shape is what most readers underweight. BPC-157's example vial is 5 mg drawn against 0.25 mg per dose at 7 doses per week. TB-500's example vial is 5 mg drawn against 2 mg per dose at 2 doses per week. Those four numbers feed every column in the table above; change any one and the bpc 157 vs tb 500 comparison shifts with it.
Concentration in this pair: BPC-157 sits at 2.50 mg/mL on the example reconstitution; TB-500 sits at 2.50 mg/mL on its example. That single ratio is what determines how many U-100 syringe units a given dose of either molecule actually draws, so it is the first thing to confirm before treating any "BPC-157 vs TB-500" unit number on the internet as authoritative.
Doses per vial in this matchup work out to roughly 20 for BPC-157 and 2 for TB-500 at the example dose sizes, with vial-duration windows near 2.9 weeks and 1.0 weeks respectively. Refill cadence follows directly from those windows, which is why the bpc 157 vs tb 500 pair shows up in planning conversations more than in pure mechanism conversations.
Mistakes specific to the BPC-157 side of this pair
When readers compare BPC-157 against TB-500, the BPC-157-side mistakes that show up most in logs are: Typing a milligram value into the calculator with the toggle still set to micrograms — produces a unit count 1000x too high. Forgetting whether the morning dose was already taken on a twice-daily protocol — almost always a logging gap, not a math problem. Reading 250 mcg as 25 units regardless of vial concentration. The unit count depends on diluent volume. Reusing the previous vial's unit count after switching to a new vial reconstituted with a different volume. Each of these gets amplified when a reader is also actively comparing against TB-500, because muscle memory from one molecule's unit math leaks into the other.
BPC-157 question worth answering up front — Why does the BPC-157 calculator default to micrograms? Because typical illustrative doses are well below 1 mg, and typing 250 mcg is much less error-prone than typing 0.25 mg. The mg-mcg toggle is still available if the protocol you are following is framed in milligrams.
BPC-157 question worth answering up front — How is BPC-157 reconstituted? Add a measured volume of bacteriostatic water through the rubber stopper, then swirl — not shake — until the lyophilized powder fully dissolves. A 5 mg vial with 2 mL of BAC water gives a concentration of 2,500 mcg per mL.
Mistakes specific to the TB-500 side of this pair
On the TB-500 side of the BPC-157 vs TB-500 decision, the recurring mistakes are: Assuming the same unit measurement as BPC-157 when they are stacked, leading to a significant under-dose of TB-500 due to its milligram-scale dosing. Entering a 2.5 mg dose into a calculator field that defaults to micrograms (mcg), resulting in a miscalculation of several orders of magnitude. Allowing a twice-weekly schedule to drift by a day each week, altering the dosing interval from a 3-day/4-day pattern to a 4-day/5-day pattern over time. Using only 1 mL of diluent for a 10 mg vial and finding the resulting solution too concentrated to measure small dose adjustments precisely on a U-100 syringe. These are not generic dosing slips — they are the ones that compound when TB-500 is being logged in parallel with BPC-157.
TB-500 question worth answering up front — Why are TB-500 doses measured in milligrams (mg) while many others are in micrograms (mcg)? The dosage scale is related to the peptide's molecular structure and the concentrations studied in research literature. TB-500 is a fragment of a larger, naturally abundant protein, and the quantities examined for biological activity are correspondingly higher than those for smaller synthetic peptides that act on highly sensitive receptors. This difference in magnitude necessitates using milligrams as the unit of measurement for accurate planning, calculation, and tracking.
TB-500 question worth answering up front — If I use a 5 mg vial and 2 mL of diluent, how many units do I draw for a 2 mg dose? With a 5 mg vial reconstituted with 2 mL of bacteriostatic water, the concentration becomes 2.5 mg per mL. To calculate a 2 mg dose, you would need 0.8 mL of the solution. On a U-100 insulin syringe, where 100 units equal 1 mL, 0.8 mL is equal to 80 units. Using a dose calculator is the most reliable way to convert your desired milligram dose into the correct syringe units.
Frequently asked questions about BPC-157 vs TB-500
Why does the BPC-157 calculator default to micrograms?
How is BPC-157 reconstituted?
How many units of BPC-157 are in 250 mcg?
Why are TB-500 doses measured in milligrams (mg) while many others are in micrograms (mcg)?
If I use a 5 mg vial and 2 mL of diluent, how many units do I draw for a 2 mg dose?
What is the rationale behind a twice-weekly administration schedule?
Related on Peptide Pilot
- Open
BPC-157 reference
Overview, mechanism, mistakes, and FAQs.
- Open
TB-500 reference
Overview, mechanism, mistakes, and FAQs.
- Open
BPC-157 calculators
Reconstitution, dose, mg ↔ units, vial duration.
- Open
TB-500 calculators
Reconstitution, dose, mg ↔ units, vial duration.
- Open
All peptide comparisons
Browse the full list of side-by-side reference pages.